- Home
- PLTR vs MRK Comparison
PLTR vs MRK Comparison
Compare PLTR & MRK Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- PLTR
- MRK
- Stock Information
- Founded
- PLTR 2003
- MRK 2000
- Country
- PLTR United States
- MRK United States
- Employees
- PLTR 3936
- MRK N/A
- Industry
- PLTR Retail: Computer Software & Peripheral Equipment
- MRK Biotechnology: Pharmaceutical Preparations
- Sector
- PLTR Technology
- MRK Health Care
- Exchange
- PLTR Nasdaq
- MRK Nasdaq
- Market Cap
- PLTR 274.2B
- MRK 218.2B
- IPO Year
- PLTR 2020
- MRK N/A
- Fundamental
- Price
- PLTR $119.15
- MRK $77.66
- Analyst Decision
- PLTR Hold
- MRK Buy
- Analyst Count
- PLTR 20
- MRK 15
- Target Price
- PLTR $88.17
- MRK $115.93
- AVG Volume (30 Days)
- PLTR 110.7M
- MRK 15.6M
- Earning Date
- PLTR 05-05-2025
- MRK 04-24-2025
- Dividend Yield
- PLTR N/A
- MRK 4.17%
- EPS Growth
- PLTR 92.54
- MRK 667.14
- EPS
- PLTR 0.23
- MRK 6.88
- Revenue
- PLTR $3,115,024,000.00
- MRK $63,922,000,000.00
- Revenue This Year
- PLTR $34.11
- MRK $2.31
- Revenue Next Year
- PLTR $28.42
- MRK $6.35
- P/E Ratio
- PLTR $516.77
- MRK $11.29
- Revenue Growth
- PLTR 33.45
- MRK 4.10
- 52 Week Low
- PLTR $20.50
- MRK $75.93
- 52 Week High
- PLTR $125.41
- MRK $134.63
- Technical
- Relative Strength Index (RSI)
- PLTR 62.07
- MRK 36.06
- Support Level
- PLTR $105.32
- MRK $78.29
- Resistance Level
- PLTR $125.26
- MRK $84.71
- Average True Range (ATR)
- PLTR 6.10
- MRK 2.30
- MACD
- PLTR 0.60
- MRK 0.08
- Stochastic Oscillator
- PLTR 83.02
- MRK 16.63
About PLTR Palantir Technologies Inc.
Palantir is an analytical software company that focuses on leveraging data to create efficiencies in its clients' organizations. The firm serves commercial and government clients via its Foundry and Gotham platforms, respectively. Palantir works only with entities in Western-allied nations and reserves the right not to work with anyone that is antithetical to Western values. The Denver-based company was founded in 2003 and went public in 2020.
About MRK Merck & Company Inc. (new)
Merck makes pharmaceutical products to treat several conditions in a number of therapeutic areas, including cardiometabolic disease, cancer, and infections. Within cancer, the firm's immuno-oncology platform is growing as a major contributor to overall sales. The company also has a substantial vaccine business, with treatments to prevent pediatric diseases as well as human papillomavirus, or HPV. Additionally, Merck sells animal health-related drugs. From a geographical perspective, just under half of the company's sales are generated in the United States.